Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_assertion type Assertion NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_head.
- NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_assertion description "[The loss of sst2 expression could represent a growth advantage in these tumors and provide an explanation for the lack of therapeutic effect of somatostatin analogues in such adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_provenance.
- NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_assertion evidence source_evidence_literature NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_provenance.
- NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_assertion SIO_000772 8620499 NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_provenance.
- NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_assertion wasDerivedFrom befree-20140225 NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_provenance.
- NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_assertion wasGeneratedBy ECO_0000203 NP759327.RA2z8AbaVSjsZ0m0xGGRryjRR0YBavK8IGRqngFZ-dMVc130_provenance.